L C C J Smans1, P M J Zelissen. 1. Department of Internal Medicine and Endocrinology, University Medical Center Utrecht, 3508 GA Utrecht, The Netherlands. L.C.C.J.Smans@umcutrecht.nl
Abstract
OBJECTIVE: To our knowledge, no case of remission in autoimmune Addison's disease has previously been reported. We describe a patient with primary adrenal insufficiency caused by autoimmune adrenalitis in whom partial remission was observed after 7 yr. CASE: A 39-yr-old male was referred because of extreme fatigue, weight loss, anorexia, nausea, and bouts of fever. During physical examination hyperpigmentation was seen. Laboratory tests showed a plasma cortisol of 0.02 micromol/l (08:30 h). Cortisol failed to increase during the ACTH stimulation test (0.02 to 0.03 micromol/l) and ACTH was markedly elevated (920 pmol/l). Adrenal auto-antibodies were weakly positive. A CT-scan showed no evidence of calcifications or other abnormalities of the adrenal glands. The diagnosis of autoimmune Addison's disease was made and replacement therapy with hydrocortisone and fludrocortisone was started. During the following years the dose of hydrocortisone was gradually decreased. Eventually, the patient decided to stop his medication completely. A repeated ACTH-stimulation test revealed a basal cortisol of 0.25 micromol/l and a peak cortisol of 0.30 micromol/l with a basal ACTH of 178 pmol/l. The patient did not have any complaints. CONCLUSION: Recovery of adrenal insufficiency, due to causes other than autoimmune adrenalitis, has been reported in the past. If our case of partial recovery of autoimmune adrenalitis is not unique this could have profound effects on treatment and follow-up of Addison's disease.
OBJECTIVE: To our knowledge, no case of remission in autoimmune Addison's disease has previously been reported. We describe a patient with primary adrenal insufficiency caused by autoimmune adrenalitis in whom partial remission was observed after 7 yr. CASE: A 39-yr-old male was referred because of extreme fatigue, weight loss, anorexia, nausea, and bouts of fever. During physical examination hyperpigmentation was seen. Laboratory tests showed a plasma cortisol of 0.02 micromol/l (08:30 h). Cortisol failed to increase during the ACTH stimulation test (0.02 to 0.03 micromol/l) and ACTH was markedly elevated (920 pmol/l). Adrenal auto-antibodies were weakly positive. A CT-scan showed no evidence of calcifications or other abnormalities of the adrenal glands. The diagnosis of autoimmune Addison's disease was made and replacement therapy with hydrocortisone and fludrocortisone was started. During the following years the dose of hydrocortisone was gradually decreased. Eventually, the patient decided to stop his medication completely. A repeated ACTH-stimulation test revealed a basal cortisol of 0.25 micromol/l and a peak cortisol of 0.30 micromol/l with a basal ACTH of 178 pmol/l. The patient did not have any complaints. CONCLUSION: Recovery of adrenal insufficiency, due to causes other than autoimmune adrenalitis, has been reported in the past. If our case of partial recovery of autoimmune adrenalitis is not unique this could have profound effects on treatment and follow-up of Addison's disease.
Authors: A De Bellis; A Bizzarro; R Rossi; V A Paglionico; T Criscuolo; G Lombardi; A Bellastella Journal: J Clin Endocrinol Metab Date: 1993-04 Impact factor: 5.958
Authors: Michael Brauckhoff; Oliver Gimm; Phuong Nguyen Thanh; Annett Bär; Jörg Ukkat; Katrin Brauckhoff; Thomas Bönsch; Henning Dralle Journal: Surgery Date: 2003-12 Impact factor: 3.982
Authors: N Takasu; T Yamada; M Takasu; I Komiya; Y Nagasawa; T Asawa; T Shinoda; T Aizawa; Y Koizumi Journal: N Engl J Med Date: 1992-02-20 Impact factor: 91.245
Authors: S Laureti; A De Bellis; V I Muccitelli; F Calcinaro; A Bizzarro; R Rossi; A Bellastella; F Santeusanio; A Falorni Journal: J Clin Endocrinol Metab Date: 1998-10 Impact factor: 5.958
Authors: Simon H S Pearce; Anna L Mitchell; Stuart Bennett; Phil King; Sukesh Chandran; Sath Nag; Shu Chen; Bernard Rees Smith; John D Isaacs; Bijay Vaidya Journal: J Clin Endocrinol Metab Date: 2012-07-05 Impact factor: 5.958
Authors: Catherine Napier; Kathleen Allinson; Earn H Gan; Anna L Mitchell; Lorna C Gilligan; Angela E Taylor; Wiebke Arlt; Simon H S Pearce Journal: J Clin Endocrinol Metab Date: 2020-07-01 Impact factor: 5.958
Authors: Annet Vulto; Ragnhildur Bergthorsdottir; Martijn van Faassen; Ido P Kema; Gudmundur Johannsson; André P van Beek Journal: Clin Endocrinol (Oxf) Date: 2019-06-20 Impact factor: 3.478